Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$1.55M+199%-$1.93M-407%-$2.59M+15.0%-$1.57M-93.8%
$1.13M+11.6%$1.02M+186%$1.01M+263%$1.01M+260%$1.01M+333%
$1.52M+26.5%$1.12M+43.7%$1.09M+51.2%$2.1M+150%$1.2M+46.2%
$7.41M+254%$12.03M+307%$7.96M$2.09M+185%
$75K$49K+308%$284K-$0-$0-100%
-$0-100%-$0-100%-$0-100%-$0-100%
-$15.08M-$49K+99.9%-$284K$0$0+100%
$1.39M+253%$421K-98.7%$394K+204%
-$6.28M-353%$11.74M$7.96M$2.48M+152%
$7.33M+251%$11.74M+298%$7.96M$2.09M+184%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Eton Pharmaceuticals, Inc. generate?
Eton Pharmaceuticals, Inc. (ETON) generated $29.5M in operating cash flow over the trailing twelve months.
What is Eton Pharmaceuticals, Inc.'s free cash flow?
After $408.0K of capital expenditures, Eton Pharmaceuticals, Inc.'s free cash flow was $29.1M over the trailing twelve months, up 1588.2% year over year.
Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?
Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.